164579-51-5 Usage
General Description
Benzenemethanamine, α-methyl-4-(2-methylpropyl)-, (S)- (9CI) is a chemical compound with the molecular formula C12H19N. It is also known as S-α-methyl-4-(2-methylpropyl)benzylamine. Benzenemethanamine, α-methyl-4-(2-methylpropyl)-, (S)- (9CI) is an enantiomer of its racemate, which means that it has a specific spatial arrangement of its atoms that gives it unique chemical properties. It is commonly used in the pharmaceutical industry as a chiral building block for the synthesis of various drugs and biologically active molecules. Benzenemethanamine, α-methyl-4-(2-methylpropyl)-, (S)- (9CI) is also used as a reagent in organic chemical reactions and as a precursor for the production of certain industrial chemicals. Overall, Benzenemethanamine, α-methyl-4-(2-methylpropyl)-, (S)- (9CI) plays an important role in the synthesis of various valuable compounds and has a wide range of applications in the chemical and pharmaceutical industries.
Check Digit Verification of cas no
The CAS Registry Mumber 164579-51-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,4,5,7 and 9 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 164579-51:
(8*1)+(7*6)+(6*4)+(5*5)+(4*7)+(3*9)+(2*5)+(1*1)=165
165 % 10 = 5
So 164579-51-5 is a valid CAS Registry Number.
164579-51-5Relevant articles and documents
APPLICATIONS OF N6-SUBSTITUTED ADENOSINE DERIVATIVE AND N6-SUBSTITUTED ADENINE DERIVATIVE TO CALMING, HYPNOSES, CONVULSION RESISTANCE, EPILEPTIC RESISTANCE, PARKINSON DISEASE RESISTANCE, AND DEMENTIA PREVENTION AND TREATMENT
-
Paragraph 0141, (2018/10/27)
PROBLEM TO BE SOLVED: To prepare analgesics, hypnotic agents, anticonvulsant agents, antiepileptics, antiparkinson drugs, dementia prophylactics, and health care food. SOLUTION: The present invention relates to an N6-substituted adenosine derivative and an N6-substituted adenine derivative selected from the group consisting of specific compounds. The present invention also relates to a pharmaceutical composition at least comprising a therapeutically effective amount of the compounds and a pharmaceutically acceptable carrier. The invention further relates to the compounds used in preparation of analgesics, hypnotic agents, anticonvulsant agents, antiepileptics, antiparkinson drugs, dementia prophylactics, and health care food. COPYRIGHT: (C)2016,JPO&INPIT